reboxetine has been researched along with raclopride in 5 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (raclopride) | Trials (raclopride) | Recent Studies (post-2010) (raclopride) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 1,802 | 132 | 419 |
| Protein | Taxonomy | reboxetine (IC50) | raclopride (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Homo sapiens (human) | 0.052 | |
| D(2) dopamine receptor | Mus musculus (house mouse) | 0.032 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Linnér, L; Schalling, M; Svensson, TH; Wadenberg, ML; Wiker, C | 1 |
| Biegon, A; Ding, YS; Fowler, J; Lin, KS; Logan, J; Pareto, D | 1 |
| Barker, RA; Brooks, DJ; Chaudhuri, KR; Clough, C; Mason, S; Pavese, N; Piccini, P; Polkey, CE; Reuter, I; Tai, YF | 1 |
| Borgkvist, A; Feltmann, K; Lindskog, M; Malmlöf, T; Schilström, B | 1 |
| Björkholm, C; Jardemark, K; Malmerfelt, A; Marcus, MM; Nyberg, S; Schilström, B; Svensson, TH | 1 |
1 trial(s) available for reboxetine and raclopride
| Article | Year |
|---|---|
Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease.
Topics: Adrenergic Uptake Inhibitors; Adult; Brain Edema; Brain Tissue Transplantation; Carbon Radioisotopes; Case-Control Studies; Caudate Nucleus; Combined Modality Therapy; Corpus Striatum; Cyclosporine; Dopamine Antagonists; Female; Fetal Tissue Transplantation; Follow-Up Studies; Humans; Huntington Disease; Immunosuppressive Agents; Lymphocytosis; Male; Middle Aged; Morpholines; Neurologic Examination; Neuropsychological Tests; Positron-Emission Tomography; Postoperative Complications; Putamen; Raclopride; Reboxetine; Stereotaxic Techniques; Tissue Survival | 2008 |
4 other study(ies) available for reboxetine and raclopride
| Article | Year |
|---|---|
Noradrenaline reuptake inhibition enhances the antipsychotic-like effect of raclopride and potentiates D2-blockage-induced dopamine release in the medial prefrontal cortex of the rat.
Topics: Adrenergic Uptake Inhibitors; Animals; Antipsychotic Agents; Avoidance Learning; Dopamine; Dopamine D2 Receptor Antagonists; Drug Synergism; Male; Morpholines; Norepinephrine; Prefrontal Cortex; Raclopride; Rats; Rats, Wistar; Reboxetine | 2002 |
Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region.
Topics: Animals; Brain; Carbon Radioisotopes; Fluorine Radioisotopes; Fluoxetine; Ligands; Morpholines; Papio; Positron-Emission Tomography; Raclopride; Reboxetine | 2005 |
Dopamine in the hippocampus is cleared by the norepinephrine transporter.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Cocaine; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Administration Routes; Drug Interactions; Hippocampus; Idazoxan; Male; Microdialysis; Morpholines; Nomifensine; Norepinephrine Plasma Membrane Transport Proteins; Raclopride; Rats; Rats, Wistar; Reboxetine; Sodium Channel Blockers; Tetrodotoxin; Time Factors; Wakefulness | 2012 |
Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Antipsychotic Agents; Avoidance Learning; Benzazepines; Dibenzothiazepines; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Male; Membrane Potentials; Morpholines; N-Methylaspartate; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Prefrontal Cortex; Pyramidal Cells; Quetiapine Fumarate; Raclopride; Rats; Reboxetine | 2013 |